Searched for
PHARMACEUTICAL LOBBYING
India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRIIndia is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual prop...- 'We're no longer paying...': Trump sets deadline for pharma firms to lower US prescription drug costs in new orderDonald Trump signed an order to cut drug costs. Pharma companies have 30 days to comply. Otherwise, the government will limit payments. The...
- US pharma tariffs would raise US drug costs by $51 billion annually, report findsA report suggests that a proposed tariff could significantly increase medicine costs in America. The analysis estimates a potential rise of...
- Trump faces pressure from US industry over China tariff on medicinesU.S. hospitals and generic drugmakers are urging President Trump to exempt medical goods from new tariffs on Chinese imports, warning of po...
- Pharmaceutical bodies welcome uniform marketing code"We welcome the UCPMP. It is a balanced order that ensures that there is a healthy and ethical engagement between the pharmaceutical indust...
- Pharma companies ask government to exempt cheap drugs from price controlThe pharmaceutical industry has sought an exemption from ceiling price for all low-priced formulations up to Rs 5 per unit. In a meeting he...
- Pharma sector marketing practices under government scannerA high-level committee formed under Niti Aayog's VK Paul held a meeting on Friday with the representatives of pharma lobby groups to review...
- Marketing practices framework: DoP panel to meet drug lobby groups"In the meeting as part of stakeholder consultations, the committee has desired to have the view of Organisation of Pharmaceutical Producer...
- Pharma lobby cries foul on GIPC’s poor ranking to IndiaGlobal Intellectual Property Centre (GIPC) index on intellectual property (IP) standards once again places India at the bottom of 45 countr...
- Govt bulk drug scheme may allow exports, tooIndia is trying to encourage local manufacture of APIs, intermediates and key starting material used in the production of drugs and cut dep...
- Covid-19: Pharma companies ask Govt to lift API's export restrictionsPharmaceutical lobby groups have urged the government to lift restrictions on export of active pharmaceutical ingredients (APIs) and formul...
- Pharma companies must adhere to marketing norms during conferences: GovtAsking the lobbies to ensure that no unethical promotion of pharma products is done during conferences, it said companies must adhere to th...
- Department of Pharmaceutical asks industry to regulate promotional practicesThe DoP secretary has told both the domestic and multinational pharma lobby groups along with the medical device industry to “strictly” com...
- NPPA hikes 21 formulations’ prices by 50%The National Pharmaceuticals Pricing Authority (NPPA) invoked paragraph 19 of the Drug Prices Control Order to grant a 50% increase in the ...
- Pharma companies seek hike in drug rates under price controlChinese API imports turn 200% costlier, making production costlier in India. Over 70% of the country’s total bulk drug requirement comes fr...
- Health ministry backs use of PET medicine bottlesThe Drugs Technical Advisory Board had in May called for a ban on PET for bottling medicines used by children and pregnant women.
- Lobby groups of pharmaceutical companies considering petition against drug banLobby groups of pharmaceutical companies are leaving no stone unturned to get the health ministry’s ban on 344 fixed-dose combination (FDC)...
- US sees millions spent for lobbying in '09US President Barack Obama might be fighting against the growing clout of lobbyists but various entities, including ExxonMobil and Chevron, ...
- Pharma companies caught in Jammu-Srinagar crossfireSrinagar and Jammu are bracing for another crisis, this time for medicine.
- Heavy lobbying by MNCs stalls US move to make drugs cheaperLegislation aimed at speeding the availability of cheaper generic drugs in the US has stalled in Congress in the face of major lobbying by ...
Load More
